Janice Schwartz and John Boscardin publish in JAGS

Janice Schwartz, MD, John Boscardin, PhD, and UCLA colleagues D.M. Tarn and Ruey-Ying published a study titled Preferences Regarding Clinical Drug Trial Elements: A Nationally Representative Survey of Older Adults With Multimorbidity in the Journal of the American Geriatrics Society.

Key findings include:
Nearly half of older adults with multimorbidity are open to participating in clinical trials for medications targeting conditions common in their age group, regardless of sex or race. Participants prefer to learn about clinical trials through their physicians, ideally in medical offices with written materials and opportunities for Q&A—not in senior centers, libraries, or pharmacies. They are also willing to travel for in-person exams and lab tests, as long as travel time is under 30 minutes each way. Additionally, they prefer to have contact with researchers at regular intervals, either monthly or every 3–4 months, throughout the trial.